Sign up
Log in
Argan (AGX) Backlog Growth Fuels The Bull Case As Valuation Debate Builds
Share
Listen to the news

Argan (AGX) has drawn fresh investor attention after recent commentary highlighted a 49.1% year over year increase in its project backlog, which is tied to rising power generation demand and supported by a strong balance sheet.

Despite the strong backlog commentary, Argan’s share price has recently given back some ground, with a 30 day share price return of 16.1% and a 90 day share price return of 32.8%. This comes even though the year to date share price return is 39.6% and the 1 year total shareholder return is 101.6%, with very large total shareholder returns over three and five years suggesting longer term momentum has been strong compared with the recent pullback.

Scan beyond Argan by reviewing a curated 75 resilient stocks with low risk scores that may appeal if you are focusing on balance sheet strength and more resilient profiles.

Argan now trades well below the average analyst price target, even after a strong year for the stock. Is that discount pointing to mispricing, or is the recent pullback a sign that market caution is reasonable?

Most Popular Narrative: 33% Undervalued

Argan’s last close of $455.15 sits well below the most followed narrative fair value of $679.80, which is based on detailed growth and profitability forecasts.

Record backlog and continued project wins across gas, renewables, water treatment, and recycling plants provide multi-year revenue visibility, indicating potential for increased operating leverage and higher gross margins as larger projects are executed successfully.

Read the complete narrative. Read the complete narrative.

Want to see what sits behind that backlog story and the fair value gap? The narrative focuses on expectations for future revenue expansion, margin assumptions, and a premium earnings multiple that is usually associated with faster growing sectors.

Result: Fair Value of $679.80 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this fair value story for Argan can quickly be challenged if gas weighted projects face decarbonization pressure or if large EPC contracts encounter delays and cost overruns.

Find out about the key risks to this Argan narrative.

Another view on Argan’s valuation

The fair value narrative points to Argan trading 33% below an estimated value of $679.80. Yet on simple earnings multiples, the picture is very different. Argan’s P/E of 39.6x is above the US Construction industry at 33.2x and above its own fair ratio of 34.4x. This suggests investors are already paying a premium that could compress if expectations reset.

For anyone weighing whether that premium reflects strength or concentration risk in gas focused projects, See what the numbers say about this price — find out in our valuation breakdown.

NYSE:AGX P/E Ratio as at Aug 2026
NYSE:AGX P/E Ratio as at Aug 2026

Next Steps

If this mix of optimism and caution around Argan has you thinking, now is a good time to review the data yourself and decide where you stand. To get a clearer view of both the upside potential and the key concerns, take a closer look at the 2 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Argan?

If Argan has sharpened your focus on quality and valuation, now is the moment to scan wider opportunities and avoid missing stocks that better fit your goals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.